Skip to main navigation Skip to search Skip to main content

ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma

  • A. Dzikiewicz-Krawczyk
  • , K. Kok
  • , I. Slezak-Prochazka
  • , J.-L. Robertus
  • , J. Bruining
  • , M. M. Tayari
  • , B. Rutgers
  • , D. de Jong
  • , J. Koerts
  • , A. Seitz
  • , J. Li
  • , B. Tillema
  • , J. E. Guikema
  • , I. M. Nolte
  • , A. Diepstra
  • , L. Visser
  • , J. Kluiver
  • , A. van den Berg

Research output: Contribution to journalComment/Letter to the editorAcademic

31 Downloads (Pure)

Abstract

Leukemia accepted article preview online, 23 March 2017. doi:10.1038/leu.2017.94
Original languageEnglish
Pages (from-to)1470-1473
JournalLeukemia
Volume31
Issue number6
Early online date2017
DOIs
Publication statusPublished - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma'. Together they form a unique fingerprint.

Cite this